As one of the world’s leading experts in pancreatic cancer, Prof Andrew Biankin is all too familiar with the aura of dread ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

The system, known as the Radiomics-based Early Detection Model, can identify subtle signs of disease before tumors are ...

Republican politician Ben Sasse shared sad news on social media Tuesday: He's expecting to die soon from pancreatic cancer. Sasse, who served in the United States Senate representing Nebraska from ...

New pancreatic cancer drug nearly doubles survival time in patients - Pancreatic cancer is the only cancer with a five-year survival rate that’s below 20% ...

The cancers showing increasing rates include bowel, thyroid, multiple myeloma, liver, kidney and pancreatic cancer, among ...